Wexford Science & Technology launches Connect Labs offering
- Delivers turn-key wet lab and support space, attractive to life science start-ups and growth companies
- Open doors on first location, Connect Labs Phoenix at 850 PBC in Phoenix, AZ
Author Archive: AZBio
Phone App Guides Healthy Rotation of Insulin Pumps, Sensors
pilot study tests how type 1 diabetes patients can use app to avoid skin complications
AZBio Launches Biennial Workforce Study
The study measures workforce needs of Arizona life science companies in the biotech, medtech, health-IT, agricultural. and industrial biotech sectors. Arizona Life Science and Healthcare organizations of all sizes are encouraged to participate.Continue reading
Phoenix-based TapRoot raises $1.4 million Seed Round to Redefine Caregiving for Cognitively Impacted Persons
Phoenix, Arizona. Jan. 16, 2023 — TapRoot Interventions & Solutions, Inc. (“TapRoot”), a Phoenix-based digital healthcare company, closed a $1.4 million dollar seed round in late December. TapRoot’s mission is to improve health outcomes for cognitively challenged persons and their caregivers via TapRoot’s digital solution, Ella®. Croghan Investments led the round followed by strategic angel investors.Continue reading
UW and TGen Researchers Use machine Learning to Make Early Detection of Cancer More Accessible
Study tests cost-effective approach utilizing cell-free DNAContinue reading
Baylor Scott & White Research Institute, TGen and OncoHost Announce New Research Study to Analyze Resistance Mechanisms in Lung Cancer
Prospective study aimed at analyzing cancer resistance mechanisms using several multiomics technologies with a follow-up period of up to five years.Continue reading
AZBio Lays Out Goals for It’s Third Decade of Impact
In 2023, AZBio celebrates its first 20 years of impact and targets reaching top-ten status in its 3rd decade.Continue reading
Arizona Governor Katie Hobbs Shares Priorities in 2023 State of the State
The Governor opened her comments with a commitment to focus on creating a better future for every family and communityContinue reading
Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
MADISON, Wis., December 9, 2022 – Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for its breast cancer radiation signature, Profile for the Omission of Local Adjuvant Radiotherapy (POLAR), at the 2022 San Antonio Breast Cancer Symposium® (SABCS®). The meta-analysis of three independent, randomized clinical trials identified which early-stage breast cancer patients benefited from radiotherapy after breast-conserving surgery.
It’s Time to Apply for Venture Madness 2023
The deadline to apply is Thursday, Jan. 12, 2023 at 3 PM MSTContinue reading